Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00XHC
|
|||
| Former ID |
DNC010567
|
|||
| Drug Name |
N,N-Diisopropyl-1'H-phenothiazine-1'-carboxamide
|
|||
| Synonyms |
CHEMBL588172; Oprea1_258691; BDBM50308413
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H22N2OS
|
|||
| Canonical SMILES |
CC(C)N(C(C)C)C(=O)N1C2=CC=CC=C2SC3=CC=CC=C31
|
|||
| InChI |
1S/C19H22N2OS/c1-13(2)20(14(3)4)19(22)21-15-9-5-7-11-17(15)23-18-12-8-6-10-16(18)21/h5-14H,1-4H3
|
|||
| InChIKey |
RSDPPDLPSMZJPP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cholinesterase (BCHE) | Target Info | Inhibitor | [1] |
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| WikiPathways | Irinotecan Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants. Bioorg Med Chem. 2010 Mar 15;18(6):2232-2244. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.